Page 6 - Formidable Asset Management News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Formidable asset management. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Formidable Asset Management Today - Breaking & Trending Today

M&G Investment Management Ltd. Buys Shares of 609,123 Lithium Americas (Argentina) Corp. (NYSE:LAAC)

M&G Investment Management Ltd. bought a new stake in Lithium Americas (Argentina) Corp. (NYSE:LAAC – Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 609,123 shares of the company’s stock, valued at approximately $3,655,000. M&G Investment Management Ltd. […] ....

Pastos Grandes , United States , Lithium Americas Argentina Corp , Mg Investment Management Ltd , Securities Exchange Commission , Formidable Asset Management , Avantax Advisory Services Inc , Apollon Wealth Management , Advisor Group , Lithium Americas , Free Report , Advisory Services , Asset Management , Wealth Management , Private Advisor Group , Get Free Report , Sal De La Puna , Salta Province , Visit Holdingschannel , Lithium Americas Argentina , Nyse Laac , Basic Material , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,

Mereo BioPharma Group (NASDAQ:MREO) Rating Reiterated by Cantor Fitzgerald

Mereo BioPharma Group (NASDAQ:MREO – Get Free Report)‘s stock had its “overweight” rating restated by equities research analysts at Cantor Fitzgerald in a research report issued on Thursday, Benzinga reports. They presently have a $7.00 target price on the stock. Cantor Fitzgerald’s price objective would suggest a potential upside of 113.41% from the company’s current […] ....

United Kingdom , United States , News Ratings For Mereo Biopharma Group Daily , Needham Company , Tejara Capital Ltd , Mereo Biopharma Group , Capital Management , Cantor Fitzgerald , Formidable Asset Management , Mereo Biopharma Group Stock , Get Free Report , Biopharma Group , Capital Partners , Capital Ltd , Asset Management , Mereo Biopharma Group Daily ,

AEON Biopharma (NASDAQ:AEON) Price Target Cut to $6.00 by Analysts at HC Wainwright

AEON Biopharma (NASDAQ:AEON – Free Report) had its price objective reduced by HC Wainwright from $18.00 to $6.00 in a research report sent to investors on Wednesday, Benzinga reports. They currently have a buy rating on the stock. AEON Biopharma Stock Down 2.5 % AEON traded down $0.04 during midday trading on Wednesday, reaching $1.54. […] ....

Vanguard Group Inc , Biopharma Inc , Biopharma Company Profile , Formidable Asset Management , Free Report , Stock Down , Get Free Report , Asset Management , Atalaya Capital Management ,